Related Experiment Videos
[Therapeutic non-compliance: a major problem in the prevention of cardiovascular diseases]
1Département de Médecine, CHU Sart Tilman, Liège 1.
Insights
Effective cardiovascular disease prevention requires managing metabolic risks like obesity and diabetes through lifestyle changes and medications. Poor patient adherence to these strategies hinders treatment efficacy and increases healthcare costs.
Area of Science:
- Cardiology
- Metabolic Diseases
- Preventive Medicine
Context:
- Cardiovascular disease (CVD) prevention hinges on managing metabolic abnormalities, including obesity, dyslipidaemias, diabetes mellitus, and arterial hypertension.
- Current strategies involve lifestyle modifications (diet, exercise, smoking cessation) and pharmacological interventions (lipid-lowering, antidiabetic, antihypertensive drugs).
- Polypathology, particularly within the metabolic syndrome, often necessitates combination drug therapy to achieve therapeutic targets.
Purpose:
- To outline the essential components of cardiovascular disease prevention strategies.
- To highlight the challenges associated with therapeutic compliance in managing metabolic risk factors.
- To underscore the impact of non-compliance on treatment efficacy and healthcare costs.
Summary:
- Cardiovascular disease prevention is achieved by correcting risk factors and managing metabolic abnormalities through lifestyle changes and medications.
- While monotherapy can be effective, combination drug therapy is frequently required for metabolic syndrome and multiple comorbidities.
- Therapeutic non-compliance to both lifestyle advice and prescribed medications is a significant issue, limiting prevention effectiveness.
Impact:
- Non-compliance with preventive strategies compromises the efficacy of CVD risk reduction efforts.
- Poor adherence significantly increases the economic burden associated with metabolic diseases and their complications.
- Improving patient compliance is crucial for optimizing CVD prevention outcomes and reducing healthcare expenditures.
Abstract:
The prevention of cardiovascular diseases relies upon the correction of risk factors and, more particularly, the optimal management of various metabolic abnormalities such as obesity, dyslipidaemias, diabetes mellitus and arterial hypertension. Such an approach first requires the adherence to life-style habits (healthy diet, physical activity and no smoking) and, in case of failure, the use of lipid-lowering drugs, antidiabetic agents and/or antihypertensive medications. Sometimes, a monotherapy may be sufficient but, in most cases, a drug combination is mandatory because of the need to reach tight therapeutic targets and of the presence of a polypathology, especially within the frame of the metabolic syndrome. Unfortunately, all surveys indicate that therapeutic compliance to non-pharmacological advice and even to drug prescriptions is far from being excellent. Such a non-compliance limits the efficacy of the prevention strategies and contributes to markedly increase the cost of metabolic diseases and associated complications.